Graham Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-177,558	Closed	-$272K	–	1226
2025 Q1	$272K	Buy	177,558 +163,386	+1,153%	+$250K	﹤0.01%	1000
2024 Q4	$35.1K	Buy	+14,172	New	+$35.1K	﹤0.01%	1163